Early monkey studies suggest that SARS-CoV-2 antibodies “whether they are triggered by an infection or a vaccine” do provide immunity, but the results need to be (1) replicated, (2) confirmed in humans, and (3) extended to determine length of immunity. In the meantime, to quote Jewel Staite: hamsters is nice.